Investorideas.com - Cannabis Stock News: Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) Reports Second Quarter Fiscal 2020 Results
www.investorideas.com - news that inspires big ideas
Cannabis stocks news - daily news on stocks on CSE, TSX, TSXV, OTC, NASDAQ and NYSE from InvestorIdeas.com
Tuesday 25 February 2020
Monday 24 February 2020
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move; (CSE: $JUSH.C) (OTCXQ: $JUSHF) (CSE: $CURA.C) (OTCQX: $CURLF), (TSXV: $JWCA.V) (OTCQX: $JWCAF)
Investor
Ideas #Potcasts; #Cannabis News and #Stocks on the Move; (CSE: $JUSH.C) (OTCXQ:
$JUSHF)
(CSE: $CURA.C) (OTCQX: $CURLF), (TSXV: $JWCA.V) (OTCQX: $JWCAF)
Delta, Kelowna, BC, February 24, 2020 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast
edition of cannabis news and
stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/02241JUSH-CURA-JWCA.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public announcements.
But
first, Cannabis Benchmarks®, a division of New Leaf Data Services, LLC, announced the
listing of three Canada Cannabis Spot Indexes (CBMKCCSI, CBMKCNLP, and
CBMKETAX), the first cannabis indexes that benchmark the wholesale price of
cannabis paid to Canadian Licensed Producers, supporting price discovery and
ultimately enabling the creation of tradable financial instruments.
The
indexes are calculated weekly using a proprietary cannabis index methodology
developed by Cannabis Benchmarks®.
●
Value is determined by the simple average
of assessed wholesale transactions for non-medical dry cannabis flower.
●
The indexes are a representation of the
average wholesale price paid across all provinces, both including and excluding
all excise taxes.
●
Cannabis Benchmarks' methodology includes
working directly with market participants from both the supply and demand
sides, including analysis of public and private data, to assess the average
wholesale price paid each week.
These
reference price benchmarks provide critical pricing data that support decision
making
related
to buying and selling at fair market price, asset and equity valuation,
compliance with accounting standards, and commodity hedging and risk
management.
Cannabis
Benchmarks® is disseminating this index data through Nasdaq's
GIDS service to aid in
providing maximum transparency to the marketplace. GIDS provides data
recipients, either directly or through a third-party distributor, the opportunity
to reduce network, administrative and data center costs by taking one data
feed, rather than many.
"Since
the Canadian adult use market opened in October 2018, industry participants -
including cultivators, processors, retailers, investors and debt and equity
analysts - have been seeking price transparency to analyze and navigate a
dynamic market currently characterized by swiftly changing market
fundamentals," said Jonathan Rubin, CEO of NLDS. "We are pleased to
be using Nasdaq's GIDS to offer the market an independent reference benchmark
to support strategic, operational and investment related decisions."
"The
Cannabis Benchmarks® Indexes are a breakthrough for market participants in need
of fair and transparent price benchmarks to better understand this emerging
commodity" said Rubin. "These indexes will become increasingly
important to physical and financial industry participants as legal cannabis
markets expand the need for trading and risk management."
Jushi Holdings Inc.
(CSE:
JUSH) (OTCXQ:
JUSHF) a globally-focused, multi-state cannabis and hemp
operator, announced that
its wholly owned subsidiary, Jushi Inc, has closed on its previously announced
acquisition of the remaining 25% interest in TGS Illinois Holdings, LLC
("TGSIH"). Jushi Inc now owns 100% of TGSIH, which through its
operating subsidiary, TGS Illinois, LLC, owns and operates two cannabis
dispensaries – one in Sauget, IL and one in Normal, IL. Each dispensary is
eligible to seek approval from the Illinois Department of Financial &
Professional Regulation ("IDFPR") to become an adult-use dispensary
and to open a second retail location.
"We
remain encouraged by the strength of demand in Illinois as evidenced by the
State's announcement that total cannabis adult-use sales during its first month
of legalization generated nearly $40 million in revenue. The recent adult-use
legalization in Illinois has brought increased consumer demand to this
previously medical only state. We believe that the Illinois market is at an
inflection point, and that this acquisition positions Jushi for significant
growth and market share gains," commented Jim Cacioppo, Chairman and Chief
Executive Officer of Jushi. "Jushi remains focused on expanding and
building out its footprint in limited license states such as Illinois and
Pennsylvania, two states in which we have confidence in their sustained market
growth opportunity."
The
two existing dispensary locations currently operate as The Green Solution but
will transition to BEYOND/HELLO branding during the year, and are located at
2021 Goose Lake Road, Sauget, IL 62206 and 501 West Northtown Road, Normal, IL
61761.
Since
Illinois's adult-use legalization went into effect January 1, 2020, the Sauget,
IL dispensary was approved by the IDFPR to conduct adult-use sales. The Normal,
IL dispensary is eligible and will seek similar IDFPR approval for adult-use
sales. The Company also plans to exercise its option to expand from two to four
dispensaries, subject to regulatory approval. The Company plans to commence
adult-use sales at both locations following pre-commencement preparations and
completion of outstanding regulatory approval.
James
E. Wagner Cultivation Corporation (TSXV:
JWCA) (OTCQX:
JWCAF), a premium cannabis brand focused on producing clean,
consistent cannabis grown using its advanced and proprietary GrowthSTORM™
aeroponic platform, reported
financial results for its fiscal first quarter ended December
31, 2019. Dollar amounts are in Canadian dollars.
Fiscal
Q1 2020 Corporate Highlights
●
Received licensing amendment from Health
Canada to double JWC2’s licensed production capacity to 44,500 square feet,
which would be an annualized production capacity of more than 9,000 kilos of
dried cannabis.
●
Average yield per plant increased to 262
grams in the first quarter of 2020, versus the average yield of 210 in the same
year-ago period.
●
Launched plans to open a 2,000 square farm
gate retail store adjoining the company’s JWC2 flagship facility, representing
a new direct-to-consumer sales channel for the company. The store is
anticipated to be the Waterloo region’s first retail cannabis store located on
a licensed cultivation site, and will serve the area’s 500,000 inhabitants. In
January, the company submitted a cannabis retail operator license application
to the Alcohol and Gaming Commission of Ontario.
●
Received a license amendment from Health
Canada for the sale and production of cannabis extracts, edibles and topicals
at the company’s JWC1 facility, allowing JWC to add kief, rosins, and pre-rolls
in various quantity formats to its product portfolio.
●
Introduced four new cannabis strains grown
using the company’s advanced GrowthSTORM™ aeroponic platform: King Tut, Dark
Helmet, West Coast Sour Diesel, and Hash Plant.
●
Engaged Kindred Partners to serve as the exclusive broker for JWC adult-use
cannabis products in Canada.
●
Entered a supply and manufacturing
agreement with CannaCure Corporation, a wholly-owned subsidiary of Heritage Cannabis Holdings, whereby
CannaCure formulates and fills JWC’s vape cartridges, for both recreational and
medical cannabis markets.
●
Began collaboration and research trial with
Fluence Bioengineering for the
performance testing of Fluence’s VYPR 2p Broad Spectrum LED lighting solution.
The trial will assess if the lighting solution can further improve JWC’s
already high level of energy efficiency and help to further optimize
cultivation performance.
Financial
Highlights
●
Revenues totaled $264,000 in fiscal Q1
2020, down 74% sequentially from $1,025,000 in fiscal Q4 2019, and compared to
$550,000 in fiscal Q1 2019. The decline in revenue was due primarily to
management’s response to market conditions and the strategic decision to defer
sales to the second quarter to maximize the revenue potential and gross margin
of produced goods. This decision was reflected in Unrealized Fair Value on
Finished Goods in the amount of $2.4 million, as compared to none at the end of
the previous quarter.
●
Loss and comprehensive loss for fiscal Q1
reduced 48% to $1.2 million or $(0.01) per share.
●
Gross margin totaled $1.8 million, compared
to $3,000 in in the same year-ago quarter.
●
Operating expenses in fiscal Q1 2020 were
$2.5 million, a 46% decrease from fiscal Q4 2019, and a 5% increase from fiscal
Q1 2019.
●
Received private placement equity funding
of approximately $1 million.
●
Secured a $4 million loan facility
available in two tranches, with $2,850,000 received during the first quarter
and the remaining portion received in the subsequent quarter.
●
Obtained convertible security funding for
up to $10 million available in two tranches, with $2 million drawn in the
subsequent quarter and the remainder available subject to mutual agreement with
the lender.
Management
Commentary:
“During our first
fiscal quarter of 2020 we made tremendous strides in many areas of our business
designed to better position JWC for success in the new year. We focused our efforts on deriving the
maximum value from all available resources and avenues, including our
biological assets, branded products, key partnerships, proprietary technologies
and newly established sales channels.”
“Our financial
results for the quarter demonstrated that despite our strengthening platform,
we were not immune to the challenges of an industry that is still evolving and
striving for balance. While revenue declined substantially, this was largely
purposeful, reflecting what we see as temporary conditions that are now set to
pivot and launch in the opposite direction in the current quarter.”
“During fiscal Q1,
we implemented a strategic response to the market. A combination of number of
factors, primarily oversupply and the lack of legal sales outlets continued to
drive the illicit market. As a result, our wholesale partners were unable to
buy our products at historical prices, driving gross margins into the negative
territory. So, we made the strategic decision to hold back on sales and
preserve our biological assets until the oversupply subsided and the
recreational market opened.”
“Our ability to
attract various sources of capital even in this challenging environment
demonstrated our strong value proposition and gave us the flexibility to pursue
our strategy. We dedicated our resources to the development of our Cannabis 2.0
products, positioning ourselves to capture the anticipated growth in the
recreational market in the current quarter. This has also included the
formation of a variety of new partnerships and obtaining key regulatory
approvals.”
“Experts are now
predicting a three times growth in industry-wide sales in 2020, as the number
of retail stores steadily increase as a result of eased regulations and the
oversupply subsides. We expect this to support the sale of significant volumes
of our products in Q2 and beyond.
“Our primary focus
will remain on becoming a highly successful cultivator and seller of clean,
consistent cannabis. Our financial outlook is unchanged for fiscal Q2 and Q3,
as we reiterate below. Combined with our industry-leading yields and lower cost
of production due to our unique GrowthSTORM™ system, we believe we can achieve
and sustain highly favorable margins and strong growth over the long term.”
Curaleaf Holdings,
Inc.
(CSE:
CURA) (OTCQX:
CURLF), a leading vertically integrated cannabis operator in
the United States, has
been approved as a Clinical Registrant in Pennsylvania
by the Commonwealth's Department of Health, Office of Medical Marijuana. Under
this designation, the Company will be permitted to open a cultivation and
processing facility and up to six dispensaries, under the Commonwealth's
medical marijuana research program.
As
a Clinical Registrant, Curaleaf will support research initiatives into the
potential medical benefits of cannabis by providing medical cannabis, expertise
and distribution to patients participating in studies.
In
announcing the awards of the clinical registrant licenses, Dr. Rachel Levine of
the Pennsylvania Department of Health remarked; "Pennsylvania remains on
the forefront for clinical research on medical marijuana. This research is
essential to providing physicians with more evidence-based research to make
clinical decisions for their patients. It is the cornerstone of our program and
the key to our clinically based, patient-focused program for those suffering
with cancer, PTSD and other serious medical conditions."
Joe
Lusardi, Chief Executive Officer of Curaleaf, said, "We thank the
Pennsylvania Department of Health for approving Curaleaf to participate in this
vital research program. The Pennsylvania State Legislature mandated research as
a component of its medical cannabis program, setting it apart from the rest of
the nation. Curaleaf has always been focused on high-quality cannabis products,
as well as superior patient care and education. We look forward to contributing
to medical research that will ultimately benefit not only the residents of the
Commonwealth, but the entire country."
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to
regulations of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Contact Investorideas.com
800-665-0411
Thursday 20 February 2020
Investorideas.com - New Hampshire House of Representatives Passes Cannabis Legalization Bill
Investorideas.com - New Hampshire House of Representatives Passes Cannabis Legalization Bill
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investorideas.com - Cannabis Stock News: Veritas Farms (OTCQB: $VFRM) Expands Distribution of its Orange Crème Lip Balm to 71 Bashas Stores in Arizona
Investorideas.com - Cannabis Stock News: Veritas Farms (OTCQB: $VFRM) Expands Distribution of its Orange Crème Lip Balm to 71 Bashas Stores in Arizona
www.investorideas.com - news that inspires big ideas
www.investorideas.com - news that inspires big ideas
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; (NASDAQ: $HUGE) (CSE: $HUGE.C) (CSE: $HOLL.C) (CSE: $INDS.C) (TSXV: $KHRN.V) (TSX: $LABS.TO)
Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; (NASDAQ: $HUGE) (CSE: $HUGE.C) (CSE: $HOLL.C) (CSE: $INDS.C) (TSXV: $KHRN.V)
(TSX: $LABS.TO)
Delta, Kelowna, BC, February 20, 2020 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast
edition of cannabis news and
stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/02201HUGE-HOLL-INDS-KHRN-LABS.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public announcements.
But
first, High Times, the most
well-known brand in Cannabis, announced
today that it received notification from FINRA that it was
granted a trading symbol, clearing a final hurdle to begin trading. Company
trading will commence with a planned listing date to be determined in the near
future. The approval provides Hightimes Holding Corp. the ability to list on
the public markets which will culminate the brand’s highly successful
Regulation A + campaign.
“This is a big step
for the company and the High Times brand. The listing of the company’s stock
will give us a trading currency that will assist us in furthering our
acquisitional goals. There is no better time to roll out this next evolution as
we enter the cannabis retail space,” Adam Levin, Executive Chairman of
Hightimes Holding Corp., noted. “With the lessons we’ve learned from other
operator’s mistakes, great management, and the current state of the industry,
now is the time for High Times to thrive!“
“With over 23,000
investors, this has been one of the most widely subscribed to offerings in
history - across any industry,” Levin continued. “We’ve proven the strength of
our brand, and of the community we represent. We’re excited for this next step.”
High Times is
committed to continuing to connect cannabis to consumers with trusted products,
across price points, and has introduced several plans this year to support
that. High Times aims to cement its place as the largest name in cannabis and
become the ultimate destination for all consumers from the canna-curious to
marijuana lifers - both in-store and in person. The continued expansion in
licensing and e-commerce, and now into retail stores, allow the globally
recognized brand the unique opportunity to reach consumers wherever they may
live. With the first two retail stores launching in Los Angeles and Las Vegas,
High Times’s digital presence provides worldwide reach.
“This feels just
like my early days in ecommerce - except in this case we already have audience,
and we’re dealing with the most well-known brand in Cannabis,” Stormy Simon,
the brand’s Chief Executive Officer, stated. “My history in ecommerce should
help the company as we develop both our retail business as well as our direct
to consumer delivery options in markets across the globe.”
FSD Pharma Inc. (NASDAQ:
HUGE) (CSE:
HUGE) announced the
sale of its 12% equity interest in Cannara
Biotech Inc. (CSE:
LOVE) to a consortium of buyers for cash proceeds of more
than $7.7 million.
The
terms of the Share Sale Transaction were negotiated at arm's length with a
group of buyers that included entities controlled by members of the Cannara
board and senior management. A substantial portion of FSD Pharma's
shareholdings in Cannara were subject to a statutory escrow expiring December
2021. Under the terms of the Share Sale Transaction, the buyers agreed to
acquire FSD Pharma's interest subject to escrow and, as such, assumed all of
the associated market risk. The Share Sale Transaction represents a 670% return
on the Company's stake in Cannara.
"This
is a very positive milestone for the shareholders and stakeholders of FSD
Pharma to recognize a 7x return in less than two years," stated Raza
Bokhari, MD, Executive Co-Chairman & CEO. "This transaction
represents, which I hope is the first of others that will follow to strengthen
our cash position on the balance sheet. Our aim is to scale up to $50 million
in disposable cash through monetizing our non-cash assets and raising new
capital from institutional and institutional grade investors in the United
States and elsewhere."
Hollister
Biosciences Inc. (CSE:
HOLL), through its Hollister Cannabis Co division, announced the
launch of its 5-pack of .5g hash-infused pre-rolls, HashBone MiniBones.
HashBones are the
#1 hash-infused pre-roll in California. Each 1G HashBone is hand-packed with an
artisan blend of 25% cold water bubble hash and 75% top-shelf flower. Each
HashBone features a pair of sativa, hybrid or indica strains, boasting enhanced
flavor and potency. Flower is sourced from California's Central Coast, while
the cold-water bubble hash is made by Hollister.
The 5-pack of .5g
hash-infused pre-rolls, HashBone MiniBones, will be distributed exclusively by
Hollister Cannabis Co.'s distribution partner, Indus Holdings, Inc. (CSE:
INDS) and is anticipated to launch by April 01, 2020
HashBone MiniBones are expected to retail at an average price of $30 (plus
tax). Based on HashBone's current customer base, we forecast demand for 65,000
units in 2020.
The CEO of
Hollister Biosciences Inc., Carl Saling shared, "Our customers have been
requesting a multi pack HashBone that would be great on the go. We are thrilled
to launch the 5-pack mini bone hash infused pre rolls. "
Khiron Life
Sciences Corp. (TSXV:
KHRN) (OTCQB:
KHRNF) announced
today its intent to bring the Company's Kuida® CBD brand to
the Spanish market. This follows receipt of a "no objection" letter
from the TSXV specific to Spain, and is subject to meeting all regulatory
approvals in that country. With the previously announced fulfillment of E.U.
cosmetic notification regulatory requirements Khiron will prepare to commercialize
Kuida to a combined skincare market of over US$6.0 billion.
"As
our European operations ramp up, we are able to bring our unique products,
consumer experience and scientific capabilities from Latin America into one of
the world's fastest growing markets.
Entry for our Kuida brand into Spain, and later Switzerland, will represent
another milestone in the Company's strategy to serve consumers across multiple
categories and markets," comments Tejinder Virk, President, Khiron Europe.
Kuida,
the first consumer brand of Khiron's wellness business unit, brings the
benefits of cannabidiol (CBD) to a comprehensive portfolio of skin and body
care products for women. Kuida was launched in Colombia in October 2018 through
retail, wholesale and online channels and is now available nationwide and
through e-commerce channels. As the Company expands Kuida distribution in
Europe, an initial soft launch in the UK will be followed by a strategic
marketing and retail campaign. Kuida will be a featured exhibitor at Cosmoprof
Worldwide Bologna 2020, which attracted over 265,000 visitors in 2019 and is
the largest such event for attendees to learn more about market leading
products and to place orders.
MediPharm Labs
Corp. (TSX:
LABS) (OTCQX:
MEDIF) announced that
Shoppers Drug Mart, Canada’s leading pharmacy retailer, has selected its
wholly-owned subsidiary, MediPharm Labs Inc., to supply high-quality cannabis
concentrate products to medical patients nationally in Canada through its
online platform Medical Cannabis by Shoppers.
Under
the terms of the agreement, MediPharm will utilize its proprietary
pharmaceutical manufacturing platform, methodologies and scientific data to
provide Medical Cannabis by Shoppers with a wide range of concentrate-based
products starting with formulated bottled oils. MediPharm will provide other
derivative products such as gel caps and topicals as they become available. The
agreement is for a three-year term subject to renewal for an additional two
years. Formulated oils provided under the agreement are expected to begin being
shipped to Shoppers within the first two months of the agreement.
“MediPharm
Labs is proud to be partnering with one of Canada’s most trusted names in
retail to bring new and innovative pharmaceutical-quality cannabis concentrate
products to Shoppers’ medical consumers across Canada,” said Pat McCutcheon,
CEO, MediPharm Labs. “With our
pharmaceutically trained team, our GMP certified platform and research licence
permitting human trials, MediPharm Labs has the ability to develop advanced
cannabis products backed by proprietary scientific research that will serve as
the foundation for further expansion of future offerings.”
Medical
Cannabis by Shoppers launched in January 2019. The platform ships products from
Canadian licensed producers directly and discreetly to customers in all
provinces and territories in Canada. Under current regulations, pharmacists
cannot dispense medical cannabis from a pharmacy.
According
to Statistics Canada, approximately 1.1 million Canadians use cannabis for
medical purposes.i MediPharm Labs is pleased to partner with a
retailer who is not only committed to providing patients with high-quality
medical cannabis from a trusted source, but guidance from specialized advisors.
Such guidance is important in ensuring patients achieve satisfaction with their
customer experience.
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Contact Investorideas.com
800-665-0411
Subscribe to:
Posts (Atom)
You can't hold a good weed stock down (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB)
You can't hold a good weed stock down (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB) : You can't hold a good weed stock down (Nasdaq: CG...
-
Investorideas.com - Cannabis Stock News: TransCanna (CSE: TCAN) Product Ranks in Leafly's Top Cannabis Strains List
-
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ...